Market Cap
$22.3B
TROW
PRICE T ROWE GROUP INC
$106.61 ▲ +0.74%
Prev close $105.83Market cap$22.3B
ConsensusStrong Sell
12-mo target$108.83 (+2.1%)
▼ Bearish
Analyst conviction 1/10
37 New Institutional Positions13 Institutional Exits Traditional Finance
Snapshot
The big-picture read on TROW right now — valuation, ownership and activity at a glance.
Cap Size
Large Cap
Analyst Consensus
Sell (0%)
Inst. Holders
50 funds
Inst. Value
$16.6B
Inst. Activity
37 buys / 13 sells
Insider Activity
$0.00 buy / $307.7K sell
Insider Net $
-$307.7K
SEC Reports
4
Congressional
1 trades
Price chart 30d -2.5%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 1, 2026 short_volume
Short Volume: TROW — 84.0% short (0.8M / 0.9M)
Short: 771,480 | Exempt: 834 | TRF Vol: 918,900 | Short Ratio: 84.0% | Off-exchange volume (dark poo
Sep 29, 2026 Insider
WIJNBERG SANDRA S was granted 163.705 shares
Director @ $104.51 ($17.1K)
Sep 29, 2026 Insider
Verma Richard R. was granted 60.83 shares
Director @ $104.51 ($6.4K)
Sep 29, 2026 Insider
Jul 31, 2026 SEC STEVENS ROBERT J was granted 314.039 shares
Director @ $104.51 ($32.8K)
T. Rowe Price reported Q2 2026 adjusted EPS of $2.57, a 2.0% beat vs. consensus of $2.52, and net revenues of $1.907B (+
8-K — Impact 5/10
Jun 30, 2026 Inst.
Allianz Asset Management GmbH — ADD
1,583,069 shares ($180.0M)
Jun 30, 2026 Inst.
May 18, 2026 SEC AMERIPRISE FINANCIAL INC — ADD
1,419,061 shares ($161.3M)
T. Rowe Price announced a leadership expansion, appointing Eric Veiel as President and Co-Head of Global Investments, an
8-K — Impact 2/10
Analyst ratings buy % +0.0%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
0% rate it Buy or better · 19 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Sep 25, 2026 | Morgan Stanley | MAINTAIN | Equal-Weight | 55% |
| Sep 9, 2026 | Evercore ISI Group | MAINTAIN | In-Line | 59% |
| Aug 31, 2026 | TD Cowen | MAINTAIN | Hold | 56% |
| Aug 10, 2026 | Evercore ISI Group | MAINTAIN | In-Line | 59% |
| Aug 3, 2026 | Keefe, Bruyette & Woods | REITERATE | Market Perform | 58% |
| Aug 3, 2026 | TD Cowen | MAINTAIN | Hold | 56% |
| Aug 3, 2026 | Evercore ISI Group | MAINTAIN | In-Line | 59% |
| Aug 3, 2026 | BMO Capital | MAINTAIN | Market Perform | 53% |
| Aug 3, 2026 | Barclays | MAINTAIN | Underweight | 54% |
| Jul 20, 2026 | TD Cowen | MAINTAIN | Hold | 56% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 0 | 0 | 11 | 6 | 2 | 0% | |
| Aug 1, 2026 | 0 | 0 | 11 | 6 | 2 | 0% | |
| Jul 1, 2026 | 0 | 0 | 11 | 6 | 2 | 0% | |
| Jun 1, 2026 | 0 | 0 | 11 | 6 | 2 | 0% | |
| May 1, 2026 | 0 | 0 | 11 | 6 | 2 | 0% | |
| Apr 1, 2026 | 0 | 0 | 11 | 6 | 2 | 0% | |
| Mar 1, 2026 | 0 | 0 | 11 | 6 | 2 | 0% | |
| Feb 1, 2026 | 0 | 0 | 11 | 6 | 2 | 0% |
Price targets
Where 12 covering analysts think TROW trades over the next 12 months.
$108.83 +2.1% upside Hold
Current$106.62 Low$90.00 Median$110.00 High$124.00 12 analysts
$90.00$124.00
Analyst rating Hold· 3.4/5 as of Oct 2, 2026
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
4 SEC filing reports analyzed · 0 bullish, 0 bearish, 0 mixed, 4 neutral · avg impact 2.8/10.
NEUTRAL8-K5/10
T. Rowe Price reported Q2 2026 adjusted EPS of $2.57, a 2.0% beat vs. consensus of $2.52, and net re
Jul 31, 2026
NEUTRAL8-K2/10
T. Rowe Price announced a leadership expansion, appointing Eric Veiel as President and Co-Head of Gl
May 18, 2026
NEUTRAL8-K2/10
T. Rowe Price Group, Inc. amended and restated the employment agreement with Glenn R. August, CEO of
Apr 22, 2026
NEUTRALDEFA14A2/10
T. Rowe Price Group Inc. is holding its 2026 Annual Meeting of Stockholders. The definitive proxy st
Mar 17, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Oct 1, 2026
short_volume
Short Volume: TROW — 84.0% short (0.8M / 0.9M)
Short: 771,480 | Exempt: 834 | TRF Vol: 918,900 | Short Ratio: 84.0% | Off-exchange volume (dark pool + OTC)
Sep 30, 2026
short_volume
Short Volume: TROW — 80.2% short (0.5M / 0.6M)
Short: 509,585 | Exempt: 287 | TRF Vol: 635,787 | Short Ratio: 80.2% | Off-exchange volume (dark pool + OTC)
Sep 24, 2026
short_volume
Short Volume: TROW — 73.4% short (0.4M / 0.6M)
Short: 439,158 | Exempt: 61 | TRF Vol: 598,602 | Short Ratio: 73.4% | Off-exchange volume (dark pool + OTC)
Sep 23, 2026
short_volume
Short Volume: TROW — 79.3% short (0.4M / 0.5M)
Short: 408,618 | Exempt: 7 | TRF Vol: 515,024 | Short Ratio: 79.3% | Off-exchange volume (dark pool + OTC)
Sep 22, 2026
short_volume
Short Volume: TROW — 82.9% short (0.5M / 0.6M)
Short: 516,668 | Exempt: 106 | TRF Vol: 623,514 | Short Ratio: 82.9% | Off-exchange volume (dark pool + OTC)
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $2.67 | $2.50–$2.89 | -5.0% | +0.1% | 3↑ 3↓ | $2.0B | 12 |
| Next Q | $2.46 | $2.20–$2.65 | 0.9% | +0.3% | 3↑ 4↓ | $2.0B | 10 |
| Current FY | $10.22 | $9.84–$10.60 | 5.1% | +0.0% | 6↑ 2↓ | $7.7B | 13 |
| Next FY | $10.32 | $9.10–$11.25 | 1.0% | +0.2% | 6↑ 4↓ | $7.9B | 13 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $2.671 | — |
| 7d ago | $2.673 | -0.002 |
| 30d ago | $2.668 | +0.003 |
| 60d ago | $2.685 | -0.014 |
| 90d ago | $2.489 | +0.182 |
Institutional ownership
Which big funds own TROW (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $16.6B total value (145,897,312 shares) as of 2026-Q2. Top holders: BlackRock,, STATE, VANGUARD. Net buying activity: 37 institutions added/increased vs 13 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| BlackRock, Inc. | 23,996,119 | $2.7B | 16.4% | — |
| STATE STREET CORP | 14,653,478 | $1.7B | 10.0% | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 13,972,686 | $1.6B | 9.6% | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 10,042,805 | $1.1B | 6.9% | — |
| GOLDMAN SACHS GROUP INC | 8,452,903 | $961.0M | 5.8% | — |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 7,163,538 | $814.4M | 4.9% | — |
| GEODE CAPITAL MANAGEMENT, LLC | 6,263,829 | $709.9M | 4.3% | — |
| MORGAN STANLEY | 4,116,868 | $468.0M | 2.8% | — |
| Invesco Ltd. | 3,955,664 | $449.7M | 2.7% | — |
| FAYEZ SAROFIM & CO | 3,923,459 | $446.1M | 2.7% | — |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| Allianz Asset Management GmbH | ADD | 1,054,993 | 1,583,069 | +50.1% | $180.0M |
| AMERIPRISE FINANCIAL INC | ADD | 1,059,623 | 1,419,061 | +33.9% | $161.3M |
| CITIGROUP INC | DOUBLED | 574,881 | 1,374,778 | +139.1% | $156.3M |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | TRIM | 1,667,304 | 1,166,762 | -30.0% | $132.6M |
| Amundi | TRIM | 1,450,652 | 900,175 | -37.9% | $102.3M |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | DOUBLED | 271,137 | 851,396 | +214.0% | $96.8M |
| BNP PARIBAS FINANCIAL MARKETS | ADD | 323,904 | 509,451 | +57.3% | $57.9M |
| NORGES BANK | NEW | — | 466,944 | — | $53.1M |
| Freestone Grove Partners LP | NEW | — | 442,445 | — | $50.3M |
| Quantinno Capital Management LP | ADD | 310,375 | 440,692 | +42.0% | $50.1M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
15 insiders, 50 transactions. Net -$307.7K — $0.00 bought, $307.7K sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 29, 2026 | WIJNBERG SANDRA S | Director | AWARD | 163.705 | $104.51 | $17.1K |
| Sep 29, 2026 | Verma Richard R. | Director | AWARD | 60.83 | $104.51 | $6.4K |
| Sep 29, 2026 | STEVENS ROBERT J | Director | AWARD | 314.039 | $104.51 | $32.8K |
| Sep 29, 2026 | WILSON ALAN D | Director | AWARD | 520.175 | $104.51 | $54.4K |
| Sep 29, 2026 | Smith Cynthia F | Director | AWARD | 77.377 | $104.51 | $8.1K |
| Sep 29, 2026 | Golston Allan C. | Director | AWARD | 60.83 | $104.51 | $6.4K |
| Sep 29, 2026 | MacLellan Robert F. | Director | AWARD | 212.463 | $104.51 | $22.2K |
| Sep 29, 2026 | DUBLON DINA | Director | AWARD | 120.45 | $104.51 | $12.6K |
| Sep 29, 2026 | DONNELLY WILLIAM P | Director | AWARD | 163.993 | $104.51 | $17.1K |
| Jun 30, 2026 | DONNELLY WILLIAM P | Director | AWARD | 576 | — | — |
Congressional trades
TROW trades disclosed by members of Congress, with disclosure delay.
1 members · 0 buys / 1 sells
| Date | Member | Party | Chamber | Type | Amount | Asset | Disclosed |
|---|---|---|---|---|---|---|---|
| Mar 20, 2026 | Kevin Hern | R | HOUSE | SELL | $15,001 - $50,000 | T. Rowe Price Group Inc | Apr 6, 2026(18d) |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for TROW.
Shares short
27,437,346
Settlement Sep 15, 2026
Change vs prior
+4.6%
Semi-monthly cycle
Days to cover
20.4
At avg daily volume
Of shares outstanding
≈12.9%
Estimate — not % of float
All TROW filing & press-release reports (4)
- 8-K reportJul 31, 2026
- 8-K reportMay 18, 2026
- 8-K reportApr 22, 2026
- DEFA14A reportMar 17, 2026